6533b85dfe1ef96bd12bde89

RESEARCH PRODUCT

A multicenter, randomized trial of posaconazole (POS) vs fluconazole (FLU) or itraconazole (ITZ) for prophylaxis of invasive fungal infections (IFIs) in neutropenic patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) receiving intensive chemotherapy

D. Angulo-gonzalezDrew J. WinstonJohn R. PerfectDavid HelfgottOliver A. CornelyAndrew J. UllmannY T GohDick StockelbergJ MaertensMario PetriniThomas J. WalshJerzy HolowieckiC. Hardalo

subject

Posaconazolemedicine.medical_specialtyTransplantationAcute myelogenous leukemia (AML)Itraconazolebusiness.industryvirusesvirus diseasesIntensive chemotherapyHematologymedicine.diseaselaw.inventionRandomized controlled triallawInternal medicineImmunologymedicinebusinessFluconazolemedicine.drug10.1016/j.bbmt.2005.11.431http://dx.doi.org/10.1016/j.bbmt.2005.11.431